Precision Bio, Nova Synthetix to Collaborate on Ricin-Free Castor Plant Development | GenomeWeb

NEW YORK (GenomeWeb News) – Precision BioSciences and Nova Synthetix today announced a deal for the use of each other's technologies to generate "non-GM," ricin-free castor plants.

Precision Bio's Directed Nuclease Editor gene editing technology and Nova's proprietary plant transformation system will be used in work covered by the agreement. The DNE technology produces genome-editing enzymes that can "insert, remove, modify, and regulate essentially any gene in mammalian or plant cells," the firms noted in a statement.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

An opinion piece in the New York Times urges lawmakers to keep genetic protections in place.

Research funding in Canada is to remain mostly the same, ScienceInsider reports.

In Science this week: random DNA replication errors play role in cancer, and more.

The Bill and Melinda Gates Foundation embarks on an open-access publishing path.